THE DEAL, AT A GLANCE
From the announcementNervonik
01What it doesNervonik is a Digital Health company focused on Advance Peripheral Nerve Stimulation Therapy.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedNervonik raised $52.5M Series B, announced 2026-04-27From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersNervonik's $52.5M Series B positions the company as a mid-sized Healthcare & Life Sciences financing in a sector with broad recent funding activity, rather than an…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Nervonik · Financing Record
Explore source-linked visual explanations for Nervonik. Unsupported claims are withheld while source review continues.
Record 3137 · Recorded date: 2026-04-27
Explore company records →